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Small Cell Carcinoma of the Urinary
Bladder: CT and MR Imaging Findings
Objective: Primary small cell carcinoma (SCC) is a rare aggressive malignan-
cy of the urinary bladder, with identical histopathology to that of the lung. The
treatment and prognosis of bladder SCC are somewhat different from those of
more frequent transitional cell carcinoma. The purpose of this study was to ana-
lyze the CT and MR imaging findings of bladder SCC.
Materials and Methods: Six adult patients (five males and one female) with
pathologically proven SCC of the urinary bladder who had undergone pelvic CT
and/or MR imaging were included in this study. The radiologic findings were retro-
spectively evaluated in terms of tumor location, texture, calcification, depth of
invasion, perivesical extension, lymph node involvement, and local or distant
metastasis, by two radiologists, who established a consensus.
Results: CT and MR images depicted all tumors as large, ill-defined, relatively
well enhancing, broad-based polypoid intramural masses with (n=3) or without
(n=3) cystic portions. Their frequent location was posterior and trigonal (n=3).
Calcification was found within one tumor, and lymphadenopathy in four. At T2-
weighted MR images, the solid portion of the tumor was relatively hypointense.
The stage at the time of diagnosis was C in three patients, and D1 in three.
Follow-up imaging showed brain metastasis in one patient and liver metastasis in
two.
Conclusion: On CT and MR images, SCC of the urinary bladder appeared as
a large, enhancing, broad-based polypoid mass. It was stage C or higher, and
lymph nodes and distant metastasis were frequent. T2-weighted MR images
showed that the solid portion of the tumor was relatively hypointense. When radi-
ologic examinations demonstrate a bladder tumor of this kind in adults, SCC of
the urinary bladder should be included in the differential diagnosis.
rimary small cell carcinoma (SCC) of the urinary bladder, histopathologi-
cally analogous to that observed in the lung, is known to be a rare aggres-
sive high-grade malignant neoplasm (1 8). Since the first report in 1981
by Cramer et al (1), approximately 150 cases were reported worldwide prior to
November 2001 (2): the studies dealt mainly with the lesions’ pathology, cytology,
urology, or urologic oncololy. In contrast to the frequency of lung SCC, SCC of the
urinary bladder accounts for only 0.48 1% of all bladder malignancies (3 6). Most
patients with this bladder tumor have shown at least muscular invasion at the time of
diagnosis and their clinical course has been highly aggressive, with early and wide-
spread metastasis (1 7) and a poor overall survival rate (2). Transurethral resection,
commonly applied in early-stage transitional cell carcinoma (TCC) of the bladder, is
known to be ineffective in the treatment of patients with SCC of the bladder (6, 7, 9.
10). Published reports have described diverse trials, including systemic platinum or cis-
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Pplatin-based chemotherapy, surgery (such as radical cystec-
tomy or cystoprostatectomy), radiotherapy, and various
combination therapies (2, 7 11).
In spite of the relatively well known histopathology and
clinical outcome of this rare bladder SCC, radiologic re-
ports describing its imaging features have not, to our
knowledge, so far been published.
The purpose of this study was to describe the computed
tomography (CT) and magnetic resonance (MR) imaging
findings of six patients with SCC of the urinary bladder,
encountered during a recent three-year period.
MATERIALS AND METHODS
Between January 2000 and January 2003, six cases of
pathologically proven SCC of the urinary bladder were
retrospectively identified at our hospital and at other asso-
ciated institutions. All patients were adults (M:F=5:1), and
were aged between 44 and 66 (mean, 56.8) years.
Preoper-ative CT was performed in all six patients, and
supplementary MR imaging in two.
For CT or MR imaging, the bladder was not filled with
air or fluid. For CT, a High Speed Advantage CTi Standard
scanner(General Electric Medical Systems, Milwaukee,
Wis., U.S.A) or a Somatom Plus VD30 (Siemens Medical
Systems, Erlangen, Germany) was used. After pre-contrast
pelvic CT, post-contrast CT was performed with 5-mm
slice thickness and 3 5-mm collimation (1 pitch, helical
CT) at 5-mm slice intervals, following the bolus injection of
Ultravist 300 (Iopromide 0.6234 g/ml, 140 150 cc,
Schering AG, Berlin, Germany). Using a GE Signa 1.5 T
MR unit (General Electric Medical Systems), MR imaging
was performed in two patients. After the intravenous injec-
tion of Magnevist (gadopentetate dimeglumine, 0.1
mmol/Kg, Schering AG), T1-weighted images (TR/TEeff
410 660/11 17 msec), fast spin-echo T2-weighted images
(TR/TE 3,200 6,000/85 132 msec; echo train length=8,
12) and gadolinium-enhanced T1-weighted images were
obtained in the axial, coronal, and sagittal planes, with pa-
rameters of 4 5 mm slice thickness with a 1 5-mm gap, a
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Table 1. Summary of the Imaging and Clinical Findings of Small Cell Carcinoma of the Urinary Bladder
No.
Age/sex/
Location
Maximal Contrast Cystic   Calcifi- Staging  
Surgery
F/U period
Imaging Diameter (cm) enhancement portion/Tumor cation Initial F/U (years)
1. 44/ M ant. and 3.8 good C (LN) D2 partial 1
CT trigonal (LN, brain) cystectomy
2. 56 / M lt. post. and 5.5 good 1/3 D1 (SV, radical 1.3
CT trigonal lt. ureter) cystectomy
3. 57 / M ant. and 3 good C (LN) D2 radical 0.9
CT lt. lat. (liver) cystectomy
4. 59 / M ant. and 4.1 good C partial 3
CT rt. lat. cystectomy
5. 66 / M rt. post 5.2 mild 1/5 D1 (SV) D2 radical 0.6
CT, MRI and trigonal (LN, liver) cystectomy
6. 59 / F post. and 8.2 mild 1/3 + D1 (ureters, total 0.8
CT, MRI trigonal LN, vagina) cystectomy
Note. M=male, F=female,  =HU at post-contrast CT scanning (good = 70 90 HU, mild = 40-60 HU),   =volume of cystic portion / volume of whole tumor
=Staging according to Jewett-Strong-Marshall system, F/U=follow-up period, rt=right, lt=left, ant.=anterior, post.=posterior, CT=computed tomography
MRI=magnetic resonance imaging, SV=seminal vesicle, LN=lymph node involvement,  = expired patients
Fig. 1. A 56-year-old male with stage-D1
SCC of the urinary bladder (Case 2).
Post-contrast pelvic CT images (A and
B) depict a broad-based polypoid mass
(m) with nonenhancing cystic or necrotic
portions in the left posterior and trigonal
area of the urinary bladder. Note the ag-
gressiveness with which this tumor in-
vades seminal vesicles (s), and oblitera-
tion of the left ureter.
AB22 22-cm field of view, 512 224 matrix and 1.5-
4 excitations.
The patients underwent radical (n=3), partial (n=2), or
total (n=1) cystectomy, and the radiologic findings were
retrospectively evaluated by two radiologists who reached
a consensus. Tumors were retrospectively evaluated in
terms of their location, size, appearance or texture, margin,
calcification, depth of invasion, perivesical extension,
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Fig. 2. A 44-year-old male with stage-C bladder SCC metastasizing to the brain
(Case 1).
Pre-contrast (A and B) and post-contrast pelvic CT images (C and D) demon-
strate a well-enhancing intramural mass in and beyond (arrow) the anterior wall
of the urinary bladder and bilateral iliac lymph nodes (n). Another mass in the
trigonal area, and multiple distant lymph nodes, are not shown here.
Postoperative follow-up brain CT (E) revealed the presence of multiple metastat-
ic nodules (arrowheads), and this patient eventually succumbed to this wide-
spread metastasis (stage D2).
Elymph node involvement, and local or distant metastasis.
Staging was classified according to the Jewett-Strong-
Marshall system (8).
RESULTS
The demographic, imaging and clinical findings of SCC
of the urinary bladder are summarized in Table 1.
At the time of initial diagnosis, four of six patients pre-
sented with gross hematuria, one with bladder irritability,
and one with suprapubic pain. Chest radiographs or chest
CT revealed no mass-like lesion suggesting primary small
cell lung carcinoma in any of the six patients.
At CT and MR imaging, all six tumors appeared as large,
broad-based polypoid masses (Figs. 1 3). Their location
within the urinary bladder was posterior and trigonal in
three patients (Figs. 1 and 3), and anterior and trigonal
(Fig. 2), anterior and right lateral, and anterior and left lat-
eral, respectively, in the other three. The maximal diame-
ter of the six tumors ranged from 3.0 to 8.2 (mean, 5.0)
cm. All were enhanced at post-contrast CT [four were well
enhanced (70 90 HU) and the other two were slightly en-
hanced (40 60 HU)] and at post-contrast MR imaging.
Unenhanced cystic or necrotic portions, occupying less
than one third of the whole tumor volume, were noted in
three tumors (Figs. 2 and 3). Calcification within the tumor
was found in one patient (Fig. 3). At the time of diagnosis,
whole-layer muscular invasion with perivesical extension
had occurred in all six cases (Figs. 1 3). Three tumors
were Jewett-Strong-Marshall stage C (Fig. 2), and the other
three were D1 (Figs. 1 and 3). Among the three patients
with a tumor at this latter stage, there was involvement of
both seminal vesicles and the left distal ureter in one male
(Fig. 1), of the anterior vagina wall and both ureters in one
female (Fig. 3), and of the right seminal vesicle in the other
male. In two patients who underwent MR imaging studies,
the signal intensity of the solid portions of the tumors was
low at T1-weighted imaging and relatively low or similar
to those of pelvic muscles at T2-weighted imaging (Fig. 3).
Pelvic lymph node involvement was found in three pa-
tients at presentation (Figs. 2 and 3); and during follow-up,
distant lymph node metastasis was noted in two patients,
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E
Fig. 3. A 59-year-old female with stage D1 SCC of the urinary bladder (Case 6).
A, B. Pre-contrast (A) and post-contrast (B) pelvic CT reveals a heterogeneously enhancing irregular mass in and beyond the posterior
wall of the urinary bladder. At the anterior aspect of the mass, there is calcification (arrowhead). Note the exophytic posterior portion of
the tumor beyond the bladder wall (arrow), and left pelvic lymphadenopathy (n).
C-E. Axial T1-weighted (C), T2-weighted (D), and post-contrast T1-weighted (E) pelvic MR images reveal that the tumor, which invades
the anterior vaginal wall (v) and pelvic lymph nodes (n), has both enhancing solid portions and non-enhancing cystic or necrotic portions.
A Foley catheter (f) is seen within the bladder. The T2-weighted image shows that the peripheral solid portions of the tumor (arrows) are
relatively hypo- or isointense compared with the anterior bladder wall.
D
BC Abrain metastasis in one (Fig. 2), and liver metastasis in two.
These three last-mentioned all expired within one year of
initial diagnosis.
DISCUSSION
A rare primary SCC of the urinary bladder is, like SCC
of the lung, highly aggressive, and involves early and wide-
spread metastasis (1 10). The five-year survival rate for
patients with SCC of the bladder is 8.1% (9) compared to
5-10% for lung cancer (2); in those whom this cancer at-
tacks, the tumor is usually at an advanced stage by the
time of diagnosis (11). Most frequently, there is metastasis
to local or distant lymph nodes, the liver, bone, the lung,
brain, adrenal gland, spleen, or abdominal cavity (10). In
our study, the maximal diameter of six tumors ranged from
3.0 to 8.2 (mean, 5.0) cm, suggesting that at presentation, a
bladder SCC is larger than a TCC, though the latter is
more frequent. Initial CT or MR imaging revealed that in
all tumors, whole-layer muscular invasion, with perivesical
extension, had occurred (stage C in three patients and
stage D1 in another three), and three of the six patients
succumbed to brain or liver metastasis within one year of
initial diagnosis.
SCC of the urinary bladder is a rare tumor occurring typ-
ically in older men who present with gross hematuria (7),
which is the most frequent clinical symptom (11). Abbas et
al. (10) found that among 97 males and 27 females with
bladder SCC, the median age at presentation was 66.1
years. Among six patients in our study, four presented
with gross hematuria, one with bladder irritability, and one
with suprapubic pain. The mean age of the six was 56.8
years, slightly younger than reported by Abbas et al. Our
study also demonstrated male predominancy, i.e. five of
six patients were male.
An SCC has a characteristic microscopic appearance,
namely sheets and nests of small round tumor cells con-
taining hyperchromatic nuclei. Most show immunohisto-
chemical staining with neuroendocrine differentiation
markers (2), a result consistent with the pathologic findings
detailed in our study. The histogenesis of SCC of the blad-
der remains unclear, with three possible explanations (12).
First, the tumor may arise from a neuroendocrine stem cell
present in the urothelium of the bladder. The second possi-
bility is that these tumors arise from poorly defined sub-
mucosal or muscularis cells of neural crest origin. Finally,
SCC may result from a metaplastic transformation of TCC,
a possibility which would explain the coexistence of TCC
in up to two thirds of patients diagnosed with SCC (13). In
our study, however, we found no such coexistence.
For treatment of SCC of the urinary bladder, various ap-
proaches have been tried: systemic platinum- or cisplatin-
based chemotherapy, surgery (such as radical cystectomy
or cystoprostatectomy), radiotherapy, and various combi-
nation therapies (2, 6 10). All our patients underwent ad-
juvant chemotherapy and/or radiotherapy in addition to
cystectomy.
In our study, CT and MR imaging depicted all the tumors
as large, broad-based polypoid masses, at stage C or high-
er, and with or without cystic or necrotic portions. All
were relatively well enhanced at post-contrast CT and MR
imaging. At the time of their diagnosis, they had already
penetrated the whole layer of the bladder wall, with or
without invasion of adjacent organs (such as a seminal
vesicle, the ureter, or vagina) or lymph nodes. In two pa-
tients who underwent MR imaging, the solid portions of
the tumors were hypointense on both T1- and T2-weighted
images (Fig. 3), though why the tumor should have shown
relatively low signal intensity, especially on T2-weighted
images, is not clear. We suggest, however, that the high
cellularity of bladder SCC may play a role in this.
The differential diagnosis of primary SCC of the urinary
bladder includes metastasis from a SCC outside of the
bladder (an SCC of the prostate, for example), a poorly
differentiated TCC, and primary or secondary lymphomas
(7). Clinically, SCC of the lung seldom metastasizes symp-
tomatically to the urinary bladder (14). Prostatic SCC,
with a worse prognosis than bladder SCC (14), contains an
adenocarcinomatous component in more than 50% of cas-
es, and this shows a positive reaction for prostate-specific
antigen and prostatic acid phosphatase (15). Grossly, SCC
of the urinary bladder, unlike TCC, appears as a polypoid
intramural mass with a broad base (5). Thus, when such a
mass is observed in the urinary bladder at imaging studies,
a rare SCC - as well as more frequent TCC - should be
considered as the differential diagnosis. In our study, how-
ever, all cases were falsely diagnosed as TCC: in none of
our patients did chest radiographs or chest CT indicate the
presence of a mass lesion suggesting primary SCC of the
lung.
In conclusion, the CT and MR images obtained in our
study depicted SCC of the urinary bladder as a large,
broad-based polypoid mass, at stage C or higher. On T2-
weighted MR images, the solid portion of the tumor tended
to be relatively hypo- or isointense to adjacent muscle.
When radiologic examinations demonstrate a bladder tu-
mor of this kind in adults, SCC of the urinary bladder
should be included in the differential diagnosis.
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